Pediatric blood & cancer
-
Pediatric blood & cancer · Dec 2009
Randomized Controlled Trial Comparative StudyLow-dose oral midazolam reduces fear and distress during needle procedures in children with cancer.
Children with cancer often mention needle procedures as the most frightening, distressing, and sometimes painful aspect of the disease and treatment. The aim was to investigate whether children experience less fear, distress, and/or pain according to parents, nurses, and children >or=7 years of age when they receive oral midazolam versus placebo before a needle is inserted in a subcutaneously implanted intravenous port. ⋯ Low-dose oral midazolam was effective in reducing fear and distress in pediatric oncology patients, especially in younger children, undergoing subcutaneous port needle insertion.